About Catalia Health
Catalia Health is a robotics artificial intelligence (AI) health care company. The company offers Mabu Care Insights platform that delivers artificial intelligence (AI) conversations to patients to help address their ongoing healthcare issues. The company was founded in 2014 and is based in San Francisco, California.
Catalia Health's Product Videos
Catalia Health's Products & Differentiators
Mabu Care Insights Platform
An AI-driven conversation system for patient support, engagement, & data collection. Remote patient management delivered via interactive healthcare conversations, generating not just content, but context, behavioral change, & empathy. Our patented AI is based on behavioral science model, tailored adaptations, & actionable data. Participants benefit from improved outcomes, efficiency, & duration of engagement. We offer AI conversations (chatbot, app, text) as well as a complete Mabu social robot conversational experience, inclusive of patient-centric support. The individual patient controls it & benefits. Patient behavioral science is leveraged in concert with content, adherence reminders, goal setting, & wellness advice. The result is a digital companion that adjusts to each patient & each unique circumstance long-term.
Research containing Catalia Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Catalia Health in 1 CB Insights research brief, most recently on Jul 18, 2022.
Expert Collections containing Catalia Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Catalia Health is included in 4 Expert Collections, including Robotics.
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Catalia Health Patents
Catalia Health has filed 2 patents.
Health informatics, Electronic health records, Behaviorism, Medical terminology, Psychotherapy
Health informatics, Electronic health records, Behaviorism, Medical terminology, Psychotherapy
Latest Catalia Health News
Aug 15, 2023
News provided by Share this article Share toX NEW YORK, Aug. 14, 2023 /PRNewswire/ -- The artificial intelligence (AI) in the healthcare market size is estimated to grow at a CAGR of 23.5% between 2022 and 2027. The market size is forecast to increase by USD 11,827.99 million. Discover some insights on market size historic period (2017 to 2021) and Forecast (2023 to 2027) before buying the full report - Request a sample report Artificial Intelligence (AI) in the Healthcare sector market – Company Analysis Company Landscape - The global artificial intelligence (AI) in the healthcare sector market is fragmented, with the presence of several global as well as regional Companies. A few prominent companies that offer artificial intelligence (AI) in the healthcare sector in the market are Ada Health GmbH, Alphabet Inc., Amazon.com Inc., Atomwise Inc., BenchSci Analytics Inc., CarePredict Inc., Catalia Health, Cyclica, Deep Genomics Inc., Entelai, Exscientia PLC, General Electric Co., Intel Corp., International Business Machines Corp., Koninklijke Philips NV, MaxQ AI, Medtronic Plc, Microsoft Corp., NVIDIA Corp., and Siemens Healthineers AG and others. What's New? - Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession Global competitiveness and key competitor positions Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy the report! Company Offerings - Alphabet Inc.: The company offers artificial intelligence in the healthcare sector such as Google Health. Amazon.com Inc.: The company offers artificial intelligence in the healthcare sector such as Amazon HealthLake. Artificial Intelligence (AI) In The Healthcare Sector Market - Segmentation Assessment Segment Overview This artificial intelligence (AI) in healthcare market report extensively covers market segmentation by application (medical imaging and diagnostics, drug discovery, virtual assistants, operations management, and others), component (software, hardware, and services), and geography (North America, Europe, APAC, South America, and Middle East and Africa). The market share growth by the medical imaging and diagnostics segment will be significant during the forecast period. Medical imaging is the creation of a visual representation of the body or the functioning of organs or tissues for the purpose of clinical analysis and medical diagnosis. Medical imaging includes X-rays, CT scans, and magnetic resonance imaging. Managing high-resolution imaging data for treatment and diagnosis is a challenge, even for large healthcare facilities and experienced clinicians. In addition, the increasing use of medical imaging data and technological advancements such as AI in healthcare are contributing to the adoption of medical imaging in healthcare practice. Hence, such factors will increase segment growth during the forecast period. Geography Overview North America is estimated to contribute 38% to the growth of the global market during the forecast period. The early adoption of the technology and the growing investment from market players such as Microsoft, Google, and IBM are indicative of the growing demand for AI in the region. The US is one of the top countries in the world in terms of the number of AI patents filed. The US and Canada together hold nearly 26% of all AI patent applications worldwide. IBM holds the majority of AI-related patents, followed by Microsoft and Google. Thus, such factors will drive the growth of the market in this region during the forecast period. For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 - Download a Sample Report Artificial Intelligence (AI) in the Healthcare Sector Market – Market Dynamics Leading Driver - The growing demand for reduced healthcare costs is notably driving AI in healthcare market growth. Optimizing the activities and resources of healthcare providers significantly reduces costs and increases efficiency. The experience of patients and healthcare professionals is improved through affordable, quality treatment and care. AI can reduce traditional medical costs and improve treatment while allowing patients to meet their own healthcare needs through the use of virtual assistants such as doctors or chatbots that reduce considerable human labor. Therefore, the demand to minimize healthcare costs will drive the AI market in the healthcare sector during the forecast period. Key Trend - The development of precision medicine is a key trend in the AI in healthcare market. AI uses DL algorithms to process large data sets to understand human genes and identify biological factors that cause disease. Drug development companies are increasingly using artificial intelligence to accelerate drug discovery in the healthcare sector. Researchers and scientists are using AI to personalize disease prevention and treatment strategies by analyzing large sets of genetic databases. In the area of precision medicine, AI is being used by healthcare providers and researchers as well as others such as medicinal product developers, and technology companies which will boost the growth of the market during the forecast period. Major challenge - Regulatory challenges to promote the safety and effectiveness of products are challenging AI in healthcare market growth. AI is recognized as a complex term with more solutions, such as DL, neural networks, and different approaches to setting up each technology. Regulatory standards for software as medical devices (SAMD) have been developed over the past few years. AI technologies must comply with regulations and data protection requirements in order to be adopted by providers and gain patients' trust. Regulatory compliance helps healthcare professionals to reduce the impact of bias and increase transparency. Therefore, these regulatory challenges can reduce the adoption of AI in the healthcare sector, which will impede the growth of the AI market in the healthcare sector during the forecast period. Driver, Trend & Challenges are the factor of market dynamics that states about consequences & sustainability of the businesses, find some insights from a sample report! What are the key data covered in this Artificial Intelligence (AI) In Healthcare Sector Market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of artificial intelligence (AI) in the healthcare sector market between 2023 and 2027 Precise estimation of the artificial intelligence (AI) in the healthcare sector market size and its contribution to the market in focus on the parent market Accurate predictions about upcoming trends and changes in consumer behavior Growth of artificial intelligence (AI) in the healthcare sector market across North America, Europe, APAC, South America, and Middle East and Africa A thorough analysis of the market's competitive landscape and detailed information about companies Comprehensive analysis of factors that will challenge the growth of artificial intelligence (AI) in the healthcare sector market companies Gain instant access to 17,000+ market research reports. Related Reports: The Artificial Intelligence (AI) in Asset Management Market size is estimated to grow at a CAGR of 37.88% between 2022 and 2027. The market size is forecast to increase by USD 10,373.18 million. Furthermore, this Artificial Intelligence (AI) in Asset Management Market report extensively covers market segmentation by deployment (on-premises and cloud), industry application (BFSI, retail and e-commerce, healthcare, energy and utilities, and others), and geography (North America, Europe, APAC, Middle East and Africa, and South America). The rapid adoption of artificial intelligence in asset management and the growing importance of asset tracking is notably driving the market growth during the forecast period. The Generative AI Market size is estimated to grow at a CAGR of 32.65% between 2022 and 2027. The market size is forecast to increase by USD 34,695.37 million. Furthermore, this generative AI market report extensively covers market segmentation by component (software and services), technology (transformers, generative adversarial networks (GANs), variational autoencoder (VAE), and diffusion networks), and geography (North America, APAC, Europe, South America, and Middle East and Africa). Artificial Intelligence (AI) In Healthcare Sector Market Scope Report Coverage Key companies profiled Ada Health GmbH, Alphabet Inc., Amazon.com Inc., Atomwise Inc., BenchSci Analytics Inc., CarePredict Inc., Catalia Health, Cyclica, Deep Genomics Inc., Entelai, Exscientia PLC, General Electric Co., Intel Corp., International Business Machines Corp., Koninklijke Philips NV, MaxQ AI, Medtronic Plc, Microsoft Corp., NVIDIA Corp., and Siemens Healthineers AG Market dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Tbale of Contents About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact
Catalia Health Frequently Asked Questions (FAQ)
When was Catalia Health founded?
Catalia Health was founded in 2014.
Where is Catalia Health's headquarters?
Catalia Health's headquarters is located at 118 2nd Street, San Francisco.
What is Catalia Health's latest funding round?
Catalia Health's latest funding round is Loan.
How much did Catalia Health raise?
Catalia Health raised a total of $8M.
Who are the investors of Catalia Health?
Investors of Catalia Health include Paycheck Protection Program, Khosla Ventures, Fusion Fund, Abstract Ventures, Ion Pacific and 19 more.
Who are Catalia Health's competitors?
Competitors of Catalia Health include Signant Health.
What products does Catalia Health offer?
Catalia Health's products include Mabu Care Insights Platform.
Who are Catalia Health's customers?
Customers of Catalia Health include Pfizer and Novartis.
Compare Catalia Health to Competitors
ClinOne is a platform for clinical trial enrollment to connect, inform, and empower patients in global clinical trials. The platform seeks to simplify site engagement through community including study updates, cohort updates, clarifications, webinars, and weekly or monthly updates making it easier for patients, caregivers, and sites to actively participate in trial. The company was founded in 2016 and is based in Needham, Massachusetts.
Datacubed Health applies individualized solutions for the capture of data, including smartphone apps, wearable, in-home, and environmental sensors, for remote engagement with patients and for virtual clinical studies. It focuses on healthcare and life sciences to improve patient retention and compliance. The company was founded in 2016 and is based in Brooklyn, New York.
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
Castor EDC is a medical research data platform. It provides a decentralized clinical trial (DCT) solutions to control clinical trial design. It analyzes, manages, and organizes medical data collected from multiple electronic records. The company was founded in 2011 and is based in New York, New York.
Eclincloud's clinical research cloud platform is an end-to-end seamless integration platform independently developed. Including electronic informed consent eConsent, electronic data collection EDC, random and drug management RTSM, electronic clinical outcome evaluation eCOA, clinical trial project management system CTMS, electronic trial master document management eTMF, risk-based monitoring system RBM, virtualized clinical research VirtualTrial, and more.
Signant Health helps connect patients and researchers to ensure data reliability, with proven solutions that simplify every step of the patient journey.